Phase II Clinical Study of the Combination Chemotherapy Regimen of Irinotecan Plus Oral Etoposide for the Treatment of Recurrent Ovarian Cancer (Tohoku Gynecologic Cancer Unit 101 Group Study)
Tadahiro Shoji, Eriko Takatori, Hideo Omi, Seisuke Kumagai, Akira Yoshizaki, Yoshihito Yokoyama, Hideki Mizunuma, Toshio Fujimoto, Tadao Takano, Nobuo Yaegashi, Toru Tase, Kenji Nakahara, Hirohisa Kurachi, Hiroshi Nishiyama, Toru Sugiyama
International Journal of Gynecologic Cancer Jan 2011, 21 (1) 44-50; DOI: 10.1097/IGC.0b013e3181ffbe9f
